참고문헌
- Petersen PE. The world oral health report 2003. Geneva: World Health Organization; 2003.
- Petersen PE. The World Oral Health Report 2003: continuous improvement of oral health in the 21st century--the approach of the WHO Global Oral Health Programme. Community Dent Oral Epidemiol 2003;31(Suppl 1):3-23. https://doi.org/10.1046/j..2003.com122.x
- Lippman SM, Hong WK. Molecular markers of the risk of oral cancer. N Engl J Med 2001;344:1323-6. https://doi.org/10.1056/NEJM200104263441710
- Reibel J. Prognosis of oral pre-malignant lesions: signifi cance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003;14:47-62. https://doi.org/10.1177/154411130301400105
- Gupta PC, Bhonsle RB, Murti PR, Daftary DK, Mehta FS, Pindborg JJ. An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special reference to nodular leukoplakia. Cancer 1989;63:2247-52. https://doi.org/10.1002/1097-0142(19890601)63:11<2247::AID-CNCR2820631132>3.0.CO;2-D
- Geum DH, Roh YC, Yoon SY, Kim HG, Lee JH, Song JM, et al. The impact factors on 5-year survival rate in patients operated with oral cancer. J Korean Assoc Oral Maxillofac Surg 2013;39:207-16. https://doi.org/10.5125/jkaoms.2013.39.5.207
- Rai B, Kaur J, Jacobs R. Direct tissue fluorescence imaging in relation to tissue, serum and salivary protoporphyrin for oral precancerous and cancerous lesions. Oral Oncol 2011;47(Suppl 1):S40.
- Wang CY, Mayo MW, Baldwin AS Jr. TNF- and cancer therapyinduced apoptosis: potentiation by inhibition of NF-kappaB. Science 1996;274:784-7. https://doi.org/10.1126/science.274.5288.784
- van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classifi cation and present concepts of management. Oral Oncol 2009;45:317-23. https://doi.org/10.1016/j.oraloncology.2008.05.016
- Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-kappaB functions as a tumour promoter in infl ammationassociated cancer. Nature 2004;431:461-6. https://doi.org/10.1038/nature02924
- Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004;6:203-8. https://doi.org/10.1016/j.ccr.2004.09.003
- Shishodia S, Aggarwal BB. Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer. Cancer Treat Res 2004;119:139-73. https://doi.org/10.1007/1-4020-7847-1_8
- Rhodus NL, Ho V, Miller CS, Myers S, Ondrey F. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev 2005;29:42-5. https://doi.org/10.1016/j.cdp.2004.10.003
- Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23: 363-98.
-
Piva MR, DE Souza LB, Martins-Filho PR, Nonaka CF, DE Santana Santos T, DE Souza Andrade ES, et al. Role of infl ammation in oral carcinogenesis (part II): CD8, FOXP3, TNF-
${\alpha}$ , TGF-${\beta}$ and NF-${\kappa}$ B expression. Oncol Lett 2013;5:1909-14. https://doi.org/10.3892/ol.2013.1302 - Chang KP, Kao HK, Wu CC, Fang KH, Chang YL, Huang YC, et al. Pretreatment interleukin-6 serum levels are associated with patient survival for oral cavity squamous cell carcinoma. Otolaryngol Head Neck Surg 2013;148:786-91. https://doi.org/10.1177/0194599813478573
- Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, et al. Expression of proinfl ammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 1999; 5:1369-79.
- Cohen RF, Contrino J, Spiro JD, Mann EA, Chen LL, Kreutzer DL. Interleukin-8 expression by head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1995;121:202-9. https://doi.org/10.1001/archotol.1995.01890020064013
- Rhodus NL, Cheng B, Myers S, Miller L, Ho V, Ondrey F. The feasibility of monitoring NF-kappaB associated cytokines: TNFalpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog 2005;44:77-82. https://doi.org/10.1002/mc.20113
- St John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:929-35. https://doi.org/10.1001/archotol.130.8.929
- Brailo V, Vucicevic-Boras V, Cekic-Arambasin A, Alajbeg IZ, Milenovic A, Lukac J. The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia. Oral Oncol 2006;42:370-3. https://doi.org/10.1016/j.oraloncology.2005.09.001
- Frodge BD, Ebersole JL, Kryscio RJ, Thomas MV, Miller CS. Bone remodeling biomarkers of periodontal disease in saliva. J Periodontol 2008;79:1913-9. https://doi.org/10.1902/jop.2008.080070
- Burke F, Relf M, Negus R, Balkwill F. A cytokine profi le of normal and malignant ovary. Cytokine 1996;8:578-85. https://doi.org/10.1006/cyto.1996.0077
- Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in infl ammation and cancer. Eur J Cancer 2005;41:2502-12. https://doi.org/10.1016/j.ejca.2005.08.016
- Rai B, Kaur J, Jacobs R, Singh J. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress. J Oral Sci 2010;52:251-6. https://doi.org/10.2334/josnusd.52.251
- Coussens LM, Werb Z. Infl ammation and cancer. Nature 2002;420: 860-7. https://doi.org/10.1038/nature01322
- Scott HR, McMillan DC, Forrest LM, Brown DJ, McArdle CS, Milroy R. The systemic infl ammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 2002;87:264-7. https://doi.org/10.1038/sj.bjc.6600466
피인용 문헌
- Correlation between IL36α and IL17 and Activity of the Disease in Selected Autoimmune Blistering Diseases vol.2017, pp.None, 2015, https://doi.org/10.1155/2017/8980534
- The measurement of serum TNF-α levels in patients with lichen planus vol.26, pp.4, 2017, https://doi.org/10.15570/actaapa.2017.26
- Salivary IL-8, IL-6 and TNF-α as Potential Diagnostic Biomarkers for Oral Cancer vol.7, pp.2, 2015, https://doi.org/10.3390/diagnostics7020021
- Therapeutic Potential of Enoxaparin in Lichen Planus: Exploring Reasons for Inconsistent Reports vol.9, pp.None, 2015, https://doi.org/10.3389/fphar.2018.00586
- Inhibitory effect of GMI, an immunomodulatory protein from Ganoderma microsporum, on myofibroblast activity and proinflammatory cytokines in human fibrotic buccal mucosal fibroblasts vol.33, pp.1, 2018, https://doi.org/10.1002/tox.22489
- Cytokines, cortisol, and nitric oxide as salivary biomarkers in oral lichen planus: a systematic review vol.32, pp.None, 2015, https://doi.org/10.1590/1807-3107bor-2018.vol32.0082
- Growth‐regulated oncogene‐α from oral submucous fibrosis fibroblasts promotes malignant transformation of oral precancerous cells vol.47, pp.9, 2015, https://doi.org/10.1111/jop.12768
- Modulation of salivary cytokines in response to alcohol, tobacco and caffeine consumption: a pilot study vol.8, pp.None, 2018, https://doi.org/10.1038/s41598-018-35094-z
- Reduced CD8+ T cells infiltration can be associated to a malignant transformation in potentially malignant oral epithelial lesions vol.23, pp.4, 2019, https://doi.org/10.1007/s00784-018-2622-8
- “Search less, verify more”—Reviewing salivary biomarkers in oral cancer detection vol.49, pp.8, 2015, https://doi.org/10.1111/jop.13003
- The Challenges of OSCC Diagnosis: Salivary Cytokines as Potential Biomarkers vol.9, pp.9, 2020, https://doi.org/10.3390/jcm9092866
- Is Topical Application of Hyaluronic Acid in Oral Lichen Planus Effective? A Randomized Controlled Crossover Study vol.10, pp.22, 2015, https://doi.org/10.3390/app10227988
- Role of Salivary MicroRNA and Cytokines in the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma vol.22, pp.22, 2015, https://doi.org/10.3390/ijms222212215
- Interleukin-6 facilitates tumor progression by inducing ferroptosis resistance in head and neck squamous cell carcinoma vol.527, pp.None, 2015, https://doi.org/10.1016/j.canlet.2021.12.011